As we know, angiogenesis plays an important role in TAMs and breast cancer expansion, and as such, miRNAs can also introduce negative regulation, with miR-497 inhibiting breast cancer angiogenesis by targeting VEGFR2 [131]. Here, KDR is linked to breast carcinoma.